Literature DB >> 26477695

Pro-permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; The Ozurdex for Retinal Vein Occlusion (ORVO) Study.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26477695     DOI： 10.1016/j.ajo.2015.09.035

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  3 in total

1.  Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-18       Impact factor: 3.117

2.  Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-30       Impact factor: 3.117

Review 3.  Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions.

Authors:  Dan Călugăru; Mihai Călugăru; Ștefan Țălu
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.